Accueil   Diary - News   All news Adocia informs about a civil action filed by Eli Lilly

Adocia informs about a civil action filed by Eli Lilly

Lyon, France, October 11th, 2018 – 6:00 pm CET - ADOCIA (Euronext Paris: FR0011184241 – ADOC) the biopharmaceutical company focused on the treatment of diabetes and other metabolic diseases with innovative formulations of approved proteins, announces that Eli Lilly and Company (“Lilly”) filed a complaint against Adocia in the United States District Court of the Southern District of Indiana on October 9th, 2018. Lilly’s complaint seeks a declaratory judgment that “the designations of inventorship currently appearing on [Lilly’s] United States Patent Nos. 9,901,623 and 9,993,555 are complete and correct, as required by the patent laws of the United States.”

 

Read the press release